PUBLICATIONS
SMC Laboratories is highly regarded worldwide as a consulting CRO that designs studies in line with the demands of pharmaceutical companies and research institutions.
In particular, in the NASH-HCC field, SMC is a highly regarded CRO, because of our unique STAM™ mice.
The results achieved with our STAM™ have been introduced in academic publications as well as scientific conferences.
Publications
2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
No.90
Front. Immunol.
"Chitinase-1 inhibition attenuates metabolic dysregulation and restores homeostasis in MASH animal models" (Front. Immunol., DOI: 10.3389/fimmu.2025.1544973, 2025)
VIEW ARTICLE 
No.89
Human Cell
“Role of hepatocellular senescence in the development of hepatocellular carcinoma and the potential for therapeutic manipulation” (Human Cell, DOI: 10.1007/s13577-025-01201-2, 2025)
VIEW ARTICLE
No.88
Cell Rep Med.,
"Treatment of IL-18-binding protein biologics suppresses fibrotic progression in metabolic dysfunction-associated steatohepatitis" (Cell Rep Med., doi: 10.1016/j.xcrm.2025.102047)
VIEW ARTICLE
No.87
Cell Rep Med.,
"Treatment of IL-18-binding protein biologics suppresses fibrotic progression in metabolic dysfunction-associated steatohepatitis" (Cell Rep Med., doi: 10.1016/j.xcrm.2025.102047)
VIEW ARTICLE
No.86
Nutrients
“Reactive Dicarbonyl Scavenging with 2-Hydroxybenzylamine Improves MASH” (Nutrients, DOI: 10.3390/nu17040610, 2025)
VIEW ARTICLE